Figure 514

![Figure 514: Nine phytocannabinoid molecular structures with demonstrated anticonvulsant activity are presented, including THC, CBD, CBDV, CBC, CBN, and CBG. These compounds represent the key cannabis-derived molecules investigated for their potential roles in seizure suppression.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Nine phytocannabinoid molecular structures with demonstrated anticonvulsant activity are presented, including THC, CBD, CBDV, CBC, CBN, and CBG. These compounds represent the key cannabis-derived molecules investigated for their potential roles in seizure suppression." />
  <figcaption>Figure 514. Nine phytocannabinoid molecular structures with demonstrated anticonvulsant activity are presented, including THC, CBD, CBDV, CBC, CBN, and CBG. These compounds represent the key cannabis-derived molecules investigated for their potential roles in seizure suppression.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>